http://www.gooznews.com/node/3045
Tue, 08/18/2009 - 08:11 — mgoozner
One clarification to this article. The House bill (H.R. 3200) does not give the drug industry a seat on the commission that will oversee comparative effectiveness research priorities. It is only Senate legislation proposed by Max Baucus that contains such language. So this "win" for Big Pharma is still not a done deal.
Oh geez, he's a democrat (Senate Finance Committee Chairman Max Baucus, D-Mont.) I have not researched the amt of $$ he has received from big pharma, nor who his former "top aide" is who now works for Big Pharma. madelyn